Section of 10.4.1 of the EU Medical Device Regulation (EU MDR) requires the identification of carcinogens, mutagens, and reproductive toxins (CMRs) and endocrine-disrupting chemicals (EDCs) over 0.1% w/w in invasive, or fluid or gas contacting materials. There is no one standard format for the output requirements.
This webinar will discuss effective and practical approaches that meet the requirements of EU MDR and how to update them based on notified body feedback.
Learning objectives:
- What are CMRs and EDCs?
- What CMRs and EDCs are in medical devices?
- How to identify CMRs and EDCs in medical devices
Speaker:
Bruce Calder, vice president of regulatory, Claigan
Webinar date:
Dec. 2, 2020
Watch the on-demand webinar
EU MDR: A Practical Approach
Medtech
Healthcare technology and medical devices are constantly evolving to improve accuracy, patient safety and patient wellness. This rapid progress also leaves these devices increasingly susceptible to quality, safety and cybersecurity issues. We offer safety and compliance testing and training to take on these, and many other issues facing the healthcare device industry.